| Product Code: ETC7529229 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iceland Pharmacogenetic Testing Market Overview |
3.1 Iceland Country Macro Economic Indicators |
3.2 Iceland Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Iceland Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Iceland Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Iceland Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Iceland Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Iceland Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Iceland Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Iceland Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Iceland Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Iceland Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Iceland Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits |
4.2.2 Growing demand for precision medicine to optimize drug therapy |
4.2.3 Rising prevalence of chronic diseases requiring personalized treatment |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenetic testing |
4.3.2 Limited reimbursement policies for pharmacogenetic testing |
4.3.3 Lack of standardized guidelines for pharmacogenetic testing |
5 Iceland Pharmacogenetic Testing Market Trends |
6 Iceland Pharmacogenetic Testing Market, By Types |
6.1 Iceland Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Iceland Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Iceland Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Iceland Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Iceland Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Iceland Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Iceland Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Iceland Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Iceland Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Iceland Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Iceland Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Iceland Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Iceland Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Iceland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Iceland Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Iceland Pharmacogenetic Testing Market Export to Major Countries |
7.2 Iceland Pharmacogenetic Testing Market Imports from Major Countries |
8 Iceland Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare providers offering pharmacogenetic testing services |
8.2 Adoption rate of pharmacogenetic testing among healthcare professionals |
8.3 Number of research studies and publications on pharmacogenetic testing |
9 Iceland Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Iceland Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Iceland Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Iceland Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Iceland Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Iceland Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Iceland Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Iceland Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Iceland Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Iceland Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Iceland Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here